Nektar Therapeutics (NKTR) Misses Q4 EPS by 24c
Nektar Therapeutics (NASDAQ: NKTR) reported Q4 EPS of ($0.41), $0.24 ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
